RNF19B
Basic information
Region (hg38): 1:32936445-32964809
Previous symbols: [ "IBRDC3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF19B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 53 | 54 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 53 | 1 | 0 |
Variants in RNF19B
This is a list of pathogenic ClinVar variants found in the RNF19B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-32936853-C-T | not specified | Uncertain significance (Dec 16, 2022) | ||
1-32936868-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
1-32936872-C-T | not specified | Uncertain significance (Jan 01, 2025) | ||
1-32936891-G-T | not specified | Uncertain significance (Jan 02, 2024) | ||
1-32936930-G-A | not specified | Uncertain significance (Jan 29, 2025) | ||
1-32936940-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
1-32936951-C-A | not specified | Uncertain significance (Jan 22, 2025) | ||
1-32936963-G-A | not specified | Uncertain significance (Oct 29, 2024) | ||
1-32937006-G-C | not specified | Uncertain significance (Apr 25, 2022) | ||
1-32937009-C-T | not specified | Uncertain significance (Aug 01, 2024) | ||
1-32937014-C-T | not specified | Uncertain significance (Sep 08, 2024) | ||
1-32937065-C-G | not specified | Uncertain significance (Apr 18, 2024) | ||
1-32937098-G-T | not specified | Uncertain significance (Sep 17, 2021) | ||
1-32937117-C-T | not specified | Uncertain significance (May 17, 2023) | ||
1-32937120-C-T | not specified | Uncertain significance (Apr 06, 2024) | ||
1-32937182-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
1-32937210-G-A | not specified | Uncertain significance (Oct 04, 2022) | ||
1-32938439-G-T | not specified | Uncertain significance (Sep 20, 2023) | ||
1-32938442-C-T | not specified | Uncertain significance (Nov 14, 2024) | ||
1-32938463-A-G | not specified | Uncertain significance (Mar 18, 2024) | ||
1-32942286-C-T | not specified | Uncertain significance (Dec 06, 2024) | ||
1-32942297-G-A | not specified | Uncertain significance (Dec 27, 2022) | ||
1-32942386-C-G | not specified | Uncertain significance (Apr 28, 2022) | ||
1-32944087-C-T | not specified | Uncertain significance (Dec 11, 2024) | ||
1-32945574-T-C | not specified | Uncertain significance (Aug 07, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNF19B | protein_coding | protein_coding | ENST00000373456 | 9 | 28241 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.924 | 0.0763 | 125715 | 0 | 33 | 125748 | 0.000131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.27 | 233 | 353 | 0.660 | 0.0000183 | 4751 |
Missense in Polyphen | 76 | 157.14 | 0.48364 | 1866 | ||
Synonymous | -0.234 | 135 | 132 | 1.03 | 0.00000740 | 1476 |
Loss of Function | 3.98 | 4 | 25.9 | 0.155 | 0.00000127 | 331 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000255 | 0.000255 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from E2 ubiquitin-conjugating enzymes UBE2L3 and UBE2L6 in the form of a thioester and then directly transfers the ubiquitin to targeted substrates, such as UCKL1 (PubMed:16709802, PubMed:27485036). Involved in the cytolytic activity of natural killer cells and cytotoxic T-cells (PubMed:10438909). Protects against staurosporin-induced cell death (PubMed:27485036). {ECO:0000269|PubMed:10438909, ECO:0000269|PubMed:16709802, ECO:0000269|PubMed:27485036}.;
- Pathway
- Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.0930
Intolerance Scores
- loftool
- 0.382
- rvis_EVS
- -0.78
- rvis_percentile_EVS
- 12.77
Haploinsufficiency Scores
- pHI
- 0.492
- hipred
- Y
- hipred_score
- 0.853
- ghis
- 0.587
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.732
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnf19b
- Phenotype
- hematopoietic system phenotype; neoplasm; immune system phenotype;
Gene ontology
- Biological process
- protein polyubiquitination;adaptive immune response;ubiquitin-dependent protein catabolic process;positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- Cellular component
- ubiquitin ligase complex;cytoplasm;endoplasmic reticulum membrane;cytosol;integral component of membrane;cytolytic granule
- Molecular function
- ubiquitin-protein transferase activity;protein binding;ubiquitin conjugating enzyme binding;metal ion binding;ubiquitin protein ligase activity